Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Teva
US Department of Justice
McKinsey
Argus Health
US Army
Johnson and Johnson
Cerilliant
Queensland Health
Fuji

Generated: August 20, 2017

DrugPatentWatch Database Preview

SELEGILINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Selegiline Hydrochloride, and what generic Selegiline Hydrochloride alternatives are available?

Selegiline Hydrochloride is a drug marketed by Boscogen, Apotex, Somerset, G And W Labs Inc, Chartwell Molecules, Lannett Holdings Inc, Dava Pharms Inc, Mylan, Apotex Inc, and Siegfried. and is included in thirteen NDAs.

The generic ingredient in SELEGILINE HYDROCHLORIDE is selegiline hydrochloride. There are seventeen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the selegiline hydrochloride profile page.

Summary for Tradename: SELEGILINE HYDROCHLORIDE

Patents:0
Applicants:10
NDAs:13
Suppliers / Packagers: see list7
Bulk Api Vendors: see list33
Clinical Trials: see list2,289
Patent Applications: see list472
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:SELEGILINE HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: SELEGILINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Boscogen
SELEGILINE HYDROCHLORIDE
selegiline hydrochloride
TABLET;ORAL074912-001Apr 30, 1998ABRXNoNo► Subscribe► Subscribe► Subscribe
Lannett Holdings Inc
SELEGILINE HYDROCHLORIDE
selegiline hydrochloride
CAPSULE;ORAL075145-001Sep 15, 2003DISCNNoNo► Subscribe► Subscribe► Subscribe
G And W Labs Inc
SELEGILINE HYDROCHLORIDE
selegiline hydrochloride
TABLET;ORAL074537-001Aug 2, 1996DISCNNoNo► Subscribe► Subscribe► Subscribe
Apotex Inc
SELEGILINE HYDROCHLORIDE
selegiline hydrochloride
TABLET;ORAL074871-001Jun 6, 1997ABRXNoYes► Subscribe► Subscribe► Subscribe
Dava Pharms Inc
SELEGILINE HYDROCHLORIDE
selegiline hydrochloride
CAPSULE;ORAL075352-001Nov 30, 1998ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
US Army
Boehringer Ingelheim
Chinese Patent Office
Deloitte
Baxter
McKinsey
Teva
Julphar
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot